Table 2.
Bioactive Molecule | Model | Effect | Source |
---|---|---|---|
20S-hydroxycholesterol | M2-10B4 bone marrow stromal cells | Inhibits adipogenesis | [15,120,130] |
↓ PPARγ expression | |||
Hen preadipocytes | ↓ C/EBPβ and FABP4 expression | ||
22S-hydroxycholesterol | M2-10B4 bone marrow stromal cells | Inhibits adipogenesis | [130] |
↓ FABP4 and LPL expression | |||
Enhances mineralisation | |||
↑ ALP, OCN expression | |||
22R-hydroxycholesterol | M2-10B4 bone marrow stromal cells | Inhibits adipogenesis and enhances mineralisation | [130] |
↓ FABP4 and LPL expression | |||
↑ ALP, OCN expression | |||
34-hydroxycholesterol | M2-10B4 bone marrow stromal cells | Reduces adipogenesis and improves mineralization | [131] |
↓ PPARγ2, LPL and FABP4 expression | |||
↑ OSX, ALP, BSP, and OCN expression | |||
49-hydroxycholesterol | M2-10B4 bone marrow stromal cells | Reduces adipogenesis and improves mineralization | [131] |
↓ PPARγ2, LPL and FABP4 expression | |||
↑ OSX, ALP, BSP, and OCN expression | |||
(−)-Epigallochatechin | Mouse 3T3-L1 preadipocytes | ↓ Triglyceride accumulation, ↓ PPARγ and C/EBPα expression | [132] |
Phosphorylation of AMPK and ACC | |||
↑ LRP 5 and 6, DVL 2, and 3 expression | [133] | ||
↓ PPARγ, C/EBPα, FABP4, LPL, and FAS expression | [134] | ||
↓ PPARγ, C/EBPα, SREBP1c, aP2, LPL, and FAS expression | [135] | ||
Mice | ↑ HSL, ATGL, CPT-1, and UCP2 expression | ||
↓ Fat tissue formation | |||
Genistein | 3T3-L1 preadipocytes | Inhibits adipogenesis and promote lipolysis | [136,137,138] |
↓ PPARγ and C/EBPα expression | |||
Mice | ↓ LPL expression and adipose tissue formation | [139] | |
Human primary adipocytes | inhibits lipid accumulation | [140] | |
↓ GPDH activity FABP, STREPB1, and FAS expression | |||
Human adipose tissue-MSC | Inhibits adipogenic differentiation | [141] | |
↓ PPARγ, GLUT-4, and SREBP-1c expression | |||
Resveratrol | 3T3-L1 cells preadipocytes | Decreases lipid accumulation | [142] |
↓ C/EBPα, LPL, FAS, and SREBP-1c expression | |||
Inhibits adipocyte differentiation | [143] | ||
↓ C/EBPβ, PPARγ, C/EBPα, and FABP4 expression | |||
Mice | Reduces body weight | [144] | |
↓ PPARγ and FAS expression |
↑ increase in expression; ↓ decrease in expression.